FDA Investigator Jorge L Guadalupe

Jorge L Guadalupe has conducted inspections on 100 sites in 15 countries as of 23 May 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
100
Last Inspection Date:
23 May 2005
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China, Puerto Rico, Netherlands, United Kingdom of Great Britain and Northern Ireland, Germany, Italy, Japan, India, Ireland, Sweden, Czechia, Virgin Islands (U.S.), Mexico, Switzerland, Belgium
FDA Investigators that have inspected at least one site in common with Jorge L Guadalupe:
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan P Kurtzberg, Alicia M Mozzachio, Alonso, An T Vu, Ana M Rivera, Anastasia G Lolas, Anastasia M Shields, Andrea J Schmidt, Angelica M Hernandez, Anissa M Vargas, Anita R Michael, Ann L Demarco, Anna Lazar, Anna M Brannen, Annette Melendez, Anthony A Charity, Anthony C Warchut, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Arwa S El Hagrasy, Ashar P Parikh, Ashutosh Rao, PhD, Azza Talaat, Barbara Janine Breithaupt, Barbara M Frazier, Binh T Nguyen, Bo Chi, PhD, Bonita S Chester, Brandon C Heitmeier, Brenda Rivera, Brenda S Zimmer, PhD, Brian R Yaun, Brooke K Higgins, Byungja E Marciante, Carl Lee, Carlos A Medina, Cassandra L Abellard, Catherine J Laufmann, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Charisse K Green, Charles R Cote, RIC, Cheryl A Clausen, Chilton L Ng, Christina Capacci Daniel, PhD, Christine E Kelley, Christopher S Keating, Chryste D Best, Claudette D Brooks, Concepcion Cruz, Jr, Constance Y Fears, Cynthia J Lee, MS, Cynthia Jim, CSO, Daniel L Obrzut, Darren S Brown, David D Anderson, PhD, Dayna I Martinez, Debra I Love, Dell S Moller, Dennis Cantellops Paite, Dianne R Manuel, Djamila Harouaka, Doan T Nguyen, PharmD, Donna Christner, Douglas A Campbell, Douglas C Kovacs, Dr. Carmelo Rosa, Dr. Chunchang Fang, Dr. Jun Liu, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Edwin Martinez, Edwin Melendez, Elena Karnaukhova, PhD, Elizabeth D Connell, Eric M Mueller, PharmD, Eva I Merced Medina, Farhana Khan, Felix J Marrero, Felix Maldonado, Frances L Dejesus, Frances Namuswe, PhD, Frank W Perrella, Frederick L Fricke, Gavin T Cua, George J Flynn, Gerald B Seaborn, Jr, Gerardo Z Vazquez, German Rivera, Gwyn G Dickinson, Hector Espinet, Hector Jcolon Torres, Herbert M Corbello, Iraida Ortiz, Israel Santiago, OCM, Ivis L Negron, Jaime E Pares, James A Lane, James C Maclaughlin, James D Planchon, James P Mcreavey, Janet L Bowen, Javier O Vega, Jennifer L Huntington, Joan M Cantellops Figueroa, John A Gonzalez, John D White, Jolanna A Norton, Jorge E Martinez, Jorge L Gonzalez, Jorge L Lajara, Jorge Martinez, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose R Hernandez, Jose R Lopez, Jose Velez, Juan Rjimenez Garcia, Juhong Liu, PhD, Junho Pak, Justine Tomasso, Karen A Wolnik, Karl D Hezel, Katherine Szestypalow, Kejun Cheng, Kenneth H Williams, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Hoefen, Krishna Ghosh, PhD, Laiza V Garcia, Lareese K Thomas, Larry K Austin, Laura E Garcia, Laurimer Kuilan Torres, LCDR Debra Emerson, LCDR Wilfred A Darang, Leonard H Lavi, Libia M Lugo, Lisa M Lopez, Lourdes Andujar, LT Luis O Rodriguez, Luella J Rossi, Luis A Carrion, Luis A Dasta, Luis Mburgos Medero, Luz N Riveradecruz, Lynda L Perry, PhD, Madushini Dharmasena, PhD, Mamta Gautam Basak, PhD, Marcellinus D Dordunoo, Margaret M Annes, Margarita Santiago, Maria A Ruttell, Maria Joselopez Barragan, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Maridalia Torres Irizarry, Marie F Morin, Marisol Faberlle, Marvin D Jones, Mary E Storch, Marybet Lopez Negron, Matthew B Casale, Medina, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Meredith P Soehl, Investigator, Michael A Charles, Michael L Casner, Michael L Chasey, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Hernandez Sanchez, Min Tang, Minerva Rogers, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Nancy G Schmidt, Nancy Rosado, Nicholas L Paulin, Nicole K Trudel, Noreen Muñiz, Pablo Feliciano, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patrick C Klotzbuecher, Patrick L Wisor, Paul E Stein, Paul L Bellamy, Paul L Figarole, Jr, Pratik S Upadhyay, DDC, Rachel C Harrington, Rafael E Cruz, Rafael Nevarez Nieves, Rakhi B Shah, Ralph H Vocque, Ramon A Hernandez, Rapti D Madurawe, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard Heath Coats, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert Rodriguez, Robert Sharpnack, Rochelle L Cross, Rosa J Motta, Rose Ashley, Roy Baby, Rumany C Penn, PharmD, Russell K Riley, S Lori Brown, PhD MPH, Saied A Asbagh, Samina S Khan, Santos E Camara, Satheesh Thomas, Scott T Ballard, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shirley J Berryman, Simone E Pitts, Sixto M Mercado Rios, Sneha S Patel, Sonia M Monges, Sony Mathews, Stacie A Woods, Stephanie A Slater, MS, Steven B Barber, Steven C Madzo, Steven M Weinman, Steven P Donald, Susan M Jackson, Susan P Bruederle, Susan T Hadman, Susanna E Ford, Syed N Ali, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Teresa I Navas, Terri L Dodds, Thao T Kwan, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tiffani D Wilson, Timothy T Kapsala, Tomika L Bivens, Torrance J Slayton, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vaishali J Patel, Vilmary Negron Rodriguez, Viviana Matta, Vlada Matusovsky, Wanda J Torres, Wayne D Mcgrath, Wayne T Smith, Wendy G Tan, PhD, William D Tingley, William Hallett, PhD, Xiaokuang Lai, PhD, Yifan Wang, Ying Xin Fan, PhD, Ying Zhang, Yong Hu, Youmin Wang, Yumi J Hiramine, Yvesna C Blaise, Zachary L Stamm, Zhong Li, PhD

Jorge L Guadalupe's Documents

Publish Date Document Type Title
November, 2000 EIR Avebe - EIR, 2000-11-01
March, 2004 FDA 483 UQUIFA MEXICO - Form 483, 2004-03-23
October, 2003 FDA 483 Response Janssen Ortho LLC - Form 483R, 2003-12-19
March, 2004 FDA 483 FERMIC, SA DE CV - Form 483, 2004-03-17
March, 2004 EIR Fermic, S.A. de C.V. - EIR, 2007-06-22
September, 2002 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2002-09-09
April, 2004 EIR Bristol-Myers Squibb Manufacturing Company Unlimited Company - EIR, 2004-04-26
January, 2003 EIR Bristol Myers Squibb Manufacturing, Co. - EIR, 2003-01-29
July, 2003 EIR N. V. Organon - EIR, 2003-07-18
July, 2004 EIR Abbott Diagnostics International, Ltd. - EIR, 2004-07-16
March, 2004 EIR Janssen Ortho LLC - EIR, 2004-03-04
October, 2002 FDA 483 Response Bayer Healthcare Manufacturing Srl - Form 483R, 2002-12-03
August, 2002 FDA 483 Response CEPH International Corporation - Form 483R, 2002-09-05
October, 2002 FDA 483 Response AbbVie Deutschland GmbH & Co KG - Form 483R, 2002-11-20
April, 2002 EIR Lonza AG - EIR, 2002-04-29
July, 2003 EIR MSD Organon - EIR, 2003-07-11
October, 2000 FDA 483 Response N.v. Organon - Form 483R, 2000-12-12
February, 2000 EIR Janssen Ortho LLC - EIR, 2000-02-18
March, 2000 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2000-03-17
July, 2003 EIR N.V. Organon - EIR, 2003-07-17
February, 2000 FDA 483 Janssen Ortho LLC - Form 483, 2000-02-18
March, 2004 FDA 483 Response Fermic, S.A. de C.V. - Form 483R, 2004-03-31
April, 2002 EIR Wyeth Pharmaceuticals Company - EIR, 2002-04-04
April, 2002 FDA 483 Lonza AG - Form 483, 2002-04-29
June, 2001 FDA 483 Abbott Chemical Plant, Inc. - Form 483, 2001-06-12
November, 2000 FDA 483 Response Avebe - Form 483R, 2000-11-23
March, 2004 EIR UQUIFA Mexico, S.A. de C.V. - EIR, 2004-04-27
October, 2003 FDA 483 Janssen Ortho LLC - Form 483, 2003-10-15
October, 2000 EIR N.v. Organon - EIR, 2000-10-20
November, 2003 EIR Northeast Pharmaceutical Group Co., Ltd. - EIR, 2003-12-02
November, 2002 FDA 483 SCHERING S.A - Form 483, 2002-11-07
March, 2001 FDA 483 Response Fidia Farmaceutici, S.p.A. - Form 483R, 2001-03-29
October, 2001 FDA 483 Kongo Chemical Co. LTD - Form 483, 2001-10-17
November, 2002 EIR Leo Pharma Manufacturing Italy SRL. - EIR, 2002-11-25
April, 2002 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2002-04-04
October, 2000 FDA 483 Response Wyeth Pharmaceuticals Company - Form 483R, 2000-10-30
March, 2001 FDA 483 Fidia Farmaceutici, S.p.A. - Form 483, 2001-03-19
August, 2002 FDA 483 CEPH International Corporation - Form 483, 2002-08-23
May, 2003 EIR Cardinal Health Manufacturing Services B.V. - EIR, 2003-05-08
February, 2001 FDA 483 McNeil Healthcare LLC. - Form 483, 2001-02-13
June, 2001 EIR AbbVie Ltd - EIR, 2001-06-12
July, 2003 FDA 483 Response N.V. Organon - Form 483R, 2003-11-04
October, 2000 EIR Wyeth Pharmaceuticals Company - EIR, 2000-10-10
March, 2004 FDA 483 Response UQUIFA Mexico, S.A. de C.V. - Form 483R, 2004-04-14
November, 2003 EIR Shanghai Ziyuan Pharmaceutical Co. Ltd. - EIR, 2003-11-24
September, 2001 EIR Cardinal Health Manufacturing Services B.V. - EIR, 2001-09-25
October, 2001 FDA 483 Yuki Gosei Kogyo Co. LTD - Form 483, 2001-10-12
March, 2003 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2003-03-13
April, 2002 FDA 483 Response Lonza AG - Form 483R, 2002-05-02
October, 2000 FDA 483 Merck Sharp & Dohme BV - Form 483, 2000-10-25
October, 2000 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2000-10-10
May, 2003 FDA 483 Cardinal Health Manufacturing Services B.V. - Form 483, 2003-05-08
October, 2003 EIR Janssen Ortho LLC - EIR, 2003-10-15
March, 2003 EIR Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - EIR, 2003-03-13
June, 2004 EIR CATALENT PR HUMACAO, INC./dba CATALENT PHARMA SOLUTIONS, LLC - EIR, 2004-06-16
October, 2002 EIR Bayer Healthcare Manufacturing Srl - EIR, 2002-10-31
April, 2000 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2000-04-27
October, 2000 EIR Merck Sharp & Dohme BV - EIR, 2000-10-25
October, 2002 FDA 483 AbbVie Deutschland GmbH & Co KG - Form 483, 2002-10-25
August, 2002 EIR CEPH International Corporation - EIR, 2002-08-23
October, 2002 EIR AbbVie Deutschland GmbH & Co KG - EIR, 2002-10-25
October, 2000 FDA 483 Response Merck Sharp & Dohme BV - Form 483R, 2000-11-06
November, 2002 FDA 483 Response Leo Pharma Manufacturing Italy SRL. - Form 483R, 2002-12-02
May, 2001 EIR Pfizer Pharmaceuticals LLC - EIR, 2001-05-09
November, 2003 FDA 483 Response Shanghai Ziyuan Pharmaceutical Co. Ltd. - Form 483R, 2004-01-26
March, 2001 EIR Fidia Farmaceutici, S.p.A. - EIR, 2001-04-26
November, 2000 FDA 483 Glucona B.V. - Form 483, 2000-11-01
October, 2000 FDA 483 MSD Organon - Form 483, 2000-10-18
February, 2004 EIR Knoll LLC - EIR, 2004-02-06
August, 2002 EIR Lilly del Caribe, Inc. (PR02) - EIR, 2002-08-08
February, 2004 FDA 483 Knoll LLC - Form 483, 2004-02-06
February, 2001 EIR McNeil Healthcare LLC. - EIR, 2001-02-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more